VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation
Olivier Kosmider(Centre National de la Recherche Scientifique), Benjamin Terrier(Inserm), Paul Breillat(Inserm), Pierre Sohier(Hôpital Cochin), R. Outh(Centre Hospitalier de Perpignan), Vivien Guillotin(Hôpital Saint-André), Mickaël Ménager(Inserm), B. Vergier(Centre Hospitalier Universitaire de Bordeaux), Eugénie Duroyon, Darragh Duffy(Inserm), Chloé Friedrich(Centre National de la Recherche Scientifique), François Lifermann(Centre Hospitalier de Dax –Côte d’Argent), Pierre Raynaud(Centre Hospitalier de Perpignan), Twinu-Wilson Chirayath(Inserm), Camille Gobeaux(Université Paris Cité), Bénédicte Oulès(Guy's Hospital), Céline Posseme(Institut Pasteur), C. Lenormand(Hôpitaux Universitaires de Strasbourg), Estibaliz Lazaro(Centre National de la Recherche Scientifique), Barbara Burroni(Hôpital Cochin), Thierry Weitten(Centre Hospitalier Intercommunal Castres-Mazamet), S. Aractingi(Délégation Paris 5), Pierre‐Louis Tharaux(Inserm), Melchior Le Mene(Centre National de la Recherche Scientifique), G. Le Guenno(Hôpital Saint-André), Aurélien Corneau(Sorbonne Université), Jérémy Boussier(Inserm), Léa Dionet(Inserm), Francesco Carbone(Inserm), Hang‐Korng Ea(Inserm), Marie Berleur(Assistance Publique – Hôpitaux de Paris), Marie Templé(Centre National de la Recherche Scientifique), Marine Luka(Inserm), Lise Willems(Centre National de la Recherche Scientifique)
Cited by 87
Related Papers
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
|Nature Medicine|2020|633
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
|Journal of Clinical Oncology|2013|543
Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias
|Leukemia|2011|464
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
|British Journal of Dermatology|2021|414